Skip to content

Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus

Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01016457
Enrollment
15
Registered
2009-11-19
Start date
2008-12-31
Completion date
2009-12-31
Last updated
2009-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Diabetes Mellitus

Brief summary

The purpose of this study is to compare glucose control, quality of life and number of hypoglycemias in preschool children before and after using a real-time glucosensor. Nocturnal hypoglycemia can be missed even when the parents check their children's blood glucose several times at night. The investigators hypothesise that nocturnal hypoglycemia can be prevented by using the sensor in this age group. As a consequence, quality of life of the families will improve. The investigators also hypothesise that diabetes control will improve at 3-6 months from the beginning of the study.

Interventions

The sensor is inserted similarly to the insulin pump. It measures sub cutaneous glucose every 5 minutes. It alerts of high and low glucose levels, according to set limits.

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* Duration of diabetes for more than 6 months * Use of insulin pump for more than 3 months

Design outcomes

Primary

MeasureTime frame
HbA1CStart of study, after 3 months, after 6 months

Secondary

MeasureTime frame
Quality of lifeBefore and after connecting to sensor
Number of night hypoglycemiasDuring 2 weeks before connecting to sensor, during connection and 3 montjs after disconnecting
Mean glucose levelDuring the first week of connecting to sensor and during the last week of connecting

Countries

Israel

Contacts

Primary ContactKineret Mazor-Aronovitch, MD
kineret@gmail.com972-3-5305022
Backup ContactOrit Pinhas-Hamiel, MD
Orit.Hamiel@sheba.health.gov.il972-3-5305015

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026